16.01.2015 Views

Policy Roundtable Abstracts - AcademyHealth

Policy Roundtable Abstracts - AcademyHealth

Policy Roundtable Abstracts - AcademyHealth

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

insurance regulators for all 50 of the United States,<br />

Washington D.C., and five U.S. territories. The NAIC<br />

has played a key role in the implementation process of<br />

the aforementioned PPACA provisions. The vast<br />

majority of insurers within the United States provide<br />

annual data on operations and financial performance<br />

that may be useful for evaluating these provisions. The<br />

NAIC panelist can provide important technical insights<br />

regarding the pros and cons of these data for research<br />

applications and can discuss key changes that may be<br />

made in data collection following passage of federal<br />

reform.<br />

America’s Health Insurance Plans (AHIP): The<br />

panel will include a member from AHIP, which is the<br />

national association for health insurers. The proposed<br />

panelist heads AHIP’s Center for <strong>Policy</strong> and Research,<br />

which conducts innovative research and proposes policy<br />

solutions on the interrelated issues of health care quality,<br />

cost and access, and insurance markets.<br />

Academic Research Community: Also included<br />

on the panel is a health economist who maintains an<br />

active research agenda investigating the market for<br />

health insurance. This person can provide insights on<br />

what is currently known and what gaps exist in our<br />

understanding of the individual and employer-based<br />

markets.<br />

Potential Discussion Questions:<br />

(1) What do we currently know about research on<br />

health insurance market structure and performance<br />

across the three segments<br />

(2) What is the current “state of the world” in terms of<br />

data sources and measures available to evaluate<br />

U.S. health insurance market structure and<br />

performance<br />

(3) What are the strengths and weaknesses of existing<br />

data sources with respect to studying each of the<br />

market segments Consider issues of variables<br />

collected, timeliness, and granularity<br />

(4) What are the key outcomes and research questions<br />

that policymakers want and need to know, given<br />

the introduction of these new regulations<br />

(5) What types of data infrastructure investments may<br />

be needed for ensuring that rigorous and<br />

generalizable research can be conducted<br />

(6) How should we think about longer-run evaluation<br />

(e.g., once 2014 happens and state exchanges are<br />

in place) Will there be a way to obtain the “big<br />

picture” or will researchers have 50 different data<br />

sources to try to track

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!